Next Article in Journal
Synthesis and Biological Evaluation of Thiophene Derivatives as Acetylcholinesterase Inhibitors
Previous Article in Journal
Ginsenoside Rb1 Attenuates Intestinal Ischemia Reperfusion Induced Renal Injury by Activating Nrf2/ARE Pathway
Article Menu

Article Versions

Export Article

Open AccessArticle
Molecules 2012, 17(6), 7206-7216; doi:10.3390/molecules17067206

Liquiritigenin Inhibits Tumor Growth and Vascularization in a Mouse Model of Hela Cells

Department of Nutrition and Food Hygiene, School of Public Health, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, Jiangsu, China
Author to whom correspondence should be addressed.
Received: 11 May 2012 / Revised: 1 June 2012 / Accepted: 7 June 2012 / Published: 12 June 2012
Download PDF [1485 KB, uploaded 18 June 2014]


Angiogenesis is one of the crucial steps in the transition of a tumor from a small, harmless cluster of mutated cells to a large, malignant growth, capable of spreading to other organs throughout the body. Vascular endothelial growth factor (VEGF) that stimulates vasculogenesis and angiogenesis is thought to be as an anti-angiogenic target for cancer therapy. Liquiritigenin (LQ), a flavanone existing in Radix glycyrrhiza, shows extensive biological activities, such as anti-inflammatory and anti-cancer properties. In our studies, liquiritigenin effectively inhibited the growth of tumors xenografted in nude mice from human cervical cancer cell line HeLa cells, and microvascular density (MVD) of the tumor exposed to liquiritigenin was reduced in a dose dependent manner, especially in the high dose group. Moreover, the expression and secretion of VEGF were down-regulated by the drug in vivo and in vitro. Therefore, liquiritigenin can be further studied on cancer and other diseases associated with VEGF up-regulation.
Keywords: cervical cancer; liquirtigenin; angiogenesis; vascular endothelial growth factor (VEGF) cervical cancer; liquirtigenin; angiogenesis; vascular endothelial growth factor (VEGF)
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Liu, Y.; Xie, S.; Wang, Y.; Luo, K.; Wang, Y.; Cai, Y. Liquiritigenin Inhibits Tumor Growth and Vascularization in a Mouse Model of Hela Cells. Molecules 2012, 17, 7206-7216.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top